Clinical Scorecard: Optimizing Contrast Media Usage in CTPA for Pulmonary Embolism: A Comparative Analysis of EID-CT and PCD-CT in the Context of Personalized Protocols

At a Glance

Key Highlights

• CTPA is the gold standard for PE diagnosis with high sensitivity (96–100%) and specificity (89–98%).
• PCD-CT technology enables higher iodine contrast-to-noise ratio (CNR) and virtual monoenergetic imaging (VMI), allowing potential CM dose reduction while maintaining image quality.
• Personalized CM protocols adapting dose to total body weight (TBW) and tube voltage (kV) improve homogeneity and reduce CM dose in EID-CT; PCD-CT uses fixed 120 kV with VMI at 55 keV and TBW-adapted CM dosing.

Guideline-Based Recommendations

Diagnosis

• Use CTPA as the primary imaging modality for suspected pulmonary embolism due to its high diagnostic accuracy.
• Apply iodinated contrast media to enhance visualization of pulmonary arteries and emboli.

Management

• Adapt CM dose to patient’s total body weight and tube voltage in EID-CT to optimize image quality and minimize CM use.
• In PCD-CT, use a standardized 120 kV scan with VMI reconstruction at 55 keV and adjust CM dose based on TBW only.
• Employ fixed injection duration (8 seconds) with saline chaser to ensure consistent CM delivery.

Monitoring & Follow-up

• Monitor patients with severe pre-existing renal insufficiency closely due to risk of contrast-induced acute kidney injury (CI-AKI).
• Evaluate image quality to ensure diagnostic sufficiency when reducing CM dose.

Risks

• Be cautious of CI-AKI in patients with renal impairment when administering iodinated CM.
• Consider ecological and financial impacts of excess CM use.

Patient & Prescribing Data

Adults undergoing CTPA for PE exclusion, excluding those scanned for other pathologies or with artifacts

TBW- and kV-adapted CM protocols in EID-CT and TBW-adapted CM protocols in PCD-CT enable CM dose reduction while maintaining diagnostic image quality.

Clinical Best Practices

• Implement personalized CM dosing protocols based on patient TBW and scanner-specific parameters.
• Utilize PCD-CT’s spectral imaging capabilities to reconstruct VMIs at low keV to enhance contrast and reduce CM dose.
• Maintain fixed CM injection duration with saline chaser to optimize contrast bolus timing.
• Exclude scans with artifacts or protocol deviations from diagnostic evaluation to ensure data integrity.
• Consider renal function status before CM administration to mitigate risk of CI-AKI.

References

• CTPA as gold standard for PE diagnosis
• Contrast-induced acute kidney injury risks
• Photon-counting detector CT technology advantages
• TBW- and kV-adapted CM protocols for dose optimization
• Environmental and financial impact of CM usage